Citigroup raises Haemonetics PT to $123
Citigroup raised its price target on Haemonetics to $123.00 from $92.00 and lifted its rating to Buy from Neutral.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.